tirzepatide surmount-1 weight loss percent 72 weeks for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Semaglutide vs. Tirzepatide for Obesity

Effectiveness: What You Get for the Money Lets look past price and examine the value you get from semaglutide vs

In primary care settings, intelligent Liver Function Testing (iLFT) automated pathways enhance the diagnostic precision and patient care by following up the abnormal LFT results (110)

Kidney function Kidneys help remove medications from the body

Were not talking about old-school diet pills or fleeting fads

If your particular GP is unhelpful, could there be another in the practice who you could see instead

The absolute risk increase for diabetic retinopathy complications was larger among patients with a history of diabetic retinopathy at baseline (semaglutide injection 8.2%, placebo 5.2%) than among patients without a known history of diabetic retinopathy (semaglutide injection 0.7%, placebo 0.4%)